Hematologist-Oncologist
2012, American Board of Internal Medicine, Hematology
2010, American Board of Internal Medicine, Medical Oncology
2007, American Board of Internal Medicine, Internal Medicine
2000, Ph.D., Yaroslavl Medical Academy, Russia
1997, M.D., summa cum laude, Yaroslavl Medical Academy, Russia
2007-2010, Hematology/Oncology, Tufts Medical Center, Boston, Massachusetts
2004-2007, Medicine, Brown University School of Medicine, Providence, Rhode Island
2004-2005, Medicine, Brown University School of Medicine, Providence, RI
2020-Present, Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation
Associate Director, Toni Stephenson Lymphoma Center, City of Hope, Duarte, CA
2020-Present, Translational Medicine Chair, SWOG Lymphoma
2014-2020, Assistant & Associate Professor of Medicine, Hematology - Oncology, OHSU, Portland, OR
2010-2014, Assistant Professor of Medicine, Hematology/Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
2001-2004, Research Scholar, Tufts University School of Medicine, Boston, MA
2000-2001, Instructor, Department of Medicine, Yaroslavl Medical Academy, Russia
1998-1999, Instructor, Department of Pathophysiology, Yaroslavl Medical Academy, Russia
"In oncology today, we are given great opportunities to make a lot of positive impact on the lives of our patients."
A board-certified clinician and talented researcher, Dr. Danilov is an internationally recognized physician, clinical trialist and translational investigator with expertise in chronic lymphocytic leukemia, mantle cell lymphoma and non-Hodgkin lymphoma. He is a Leukemia & Lymphoma Society Scholar and a Principal Investigator on multiple grants from the National Cancer Institute, Leukemia and Lymphoma Society, American Society of Hematology, and Lymphoma Research Foundation. He has initiated and led several dozen clinical trial protocols using novel targeted therapies and immunotherapies. Through partnerships with the National Cancer Institute and pharmaceutical industry and his leadership in the Lymphoma Committee at Southwest Oncology Group, Dr. Danilov participates in drug discovery on a global scale.
Dr. Danilov directs the City of Hope e ort in early phase clinical investigations through the National Cancer Institute Experimental Therapeutics Clinical Trials Network. As a Co-Director of the Toni Stephenson Lymphoma Center, Dr. Danilov leads clinical and translational e orts in lymphoma/leukemia at City of Hope.
An ideal fit for City of Hope, Dr. Danilov's lab concentrates on "bench to bedside" medicine, where preclinical findings lead to early phase clinical trials, ultimately translating into real treatments for real patients.